Seelos Therapeutics Inc (SEEL)

[eicoman]

ok growth, here's what happened, I had no idea the Nasdaq extension only covers 1 of the 2 deficiencies which are; price over $1 and m-cap over $35M, I asked matt beck about the 2 deficiencies and he said nothing, I asked Pascoe what was the deal and he said Oh we can always get an extension, so they all knew this was coming, denner included, I fault myself for not knowing that rule, but no one I know either knew it or told me about it, so I;m really pissed off, the R/S was obvious given the rule, also have you ever heard of this ruling

also I have never seen a company dilute then 2 weeks after reverse split,

so by NOV 29th they need an extension from nasdaq or M-Cap over $35M, it will take some heavy news to get to a $35M market cap, so I expect an extension on the m-cap,

with these 2 moves I see 6-8 more months and an FDA approval to get this over a $35M m-cap, which is now 4.55 per share

they always go with the bad news first making the good news less potent, 10 launches coming and an FDA approval is looking good, so it's another number of months of waiting , I really wish i had dug more into the nasdaq ruling